Pfizer Q4 Results: $14.25B In Revenue And EPS Of $0.1, Exceeding Forecasts
January 30, 2024 at 09:05 AM EST
Pfizer reports Q4 2023 with strong financial results, achieving $14.25 billion in revenue and an EPS of $0.1.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.